key information
- Location: The Marker, 501 Geary Street, San Francisco, CA 94102, United States
- November 16-17, 2023
- 8:30 - 17:30 Local Time
OUR CONFERENCE PROGRAM
This is not just another PPM conference. This is a conference which tells you a STORY. One story, followed by another, stories of exceptional people who happen to choose Project and Portfolio Management as their way to bring needed medicines to improve the health of millions of people on our planet. Our conference will feature numerous assisted networking sessions which will help you create those critical business friendships needed for fruitful cooperation with professionals from the industry for many years to come. We believe, that our thoughtfully planned conference will fill in any missing pieces in your
plans on the mission to deliver your projects faster, more efficiently and with ease and satisfaction.
Main Takeaways
- Leveraging technologies for improved decision making
- Deciding on the right mix of therapeutic areas
- Decision analysis and structured decision making
- Assesing portfolio risk and return under multiple future scenario predictions
- Governance and risk management
- Deep dive into artificial intelligence (AI), machine learning, and predictive analytics to improve decision-making
- Alligining project and program execution to corporate strategy
- Capacity planning in a resource-constrained environment
Testimonials
- 38% CXO, MD, Chairman, President, VP, Executive Director & General Manager
- 27% Senior Patient Experience/Relations Management & Service Excellence Executives
- 20% Administration & Quality assurance management
- 15% Others: Nursing management, Clinicians, data management, pharmacy directors
Event Speakers
Manfred Schwaiger
Roche
Sarah Gonzalez
Arcus Biosciences
Edoardo Madussi
Intelligencia AI
Richard Sonnenblick
Planview
Susan Whitehead
PACT Pharma
Christine Yang
Tyra Biosciences
Usha Kidambi
Daiichi Sankyo
Ailsa Mendez
M3 Wake Research
Wouter Schul
BioMarin Pharmaceutical
Laura Grebene
Genentech
Christopher Vandepas
Guardant Health
Cynthia Shafer
Arcus Biosciences
Richard Bayney
Project & Portfolio Value Creation
Michelle Snowden
Genentech
Elise Brownell
Zephyr Biotech
Casey Owens
Independent (former Eikon Therapeutics)
Maithili Dalvi
Gilead Sciences
Erika Cruz
Eli Lilly and Company
Nicole Jackson
Golden Gate University
Besaint Mehta Sahni
Advanced Energy
Ailsa Mendez
M3 Wake Research
Hana Janouskova
Roche
Parag Jog
AbbVie
Mandy Sharma
Exelixis
Mike Horne
Golden Gate University
Joe Stalder
Zentalis
Michelle Venezia
University of Rochester Medical Center
Stephen Smith
Corcept Therapeutics
Patrice Bruneman
Pfizer
HELD AT THE SAME VENUE
PROJECT, PROGRAM, AND PORTFOLIO RISK ANALYSIS MASTERCLASS
Learn how to frame decision problems and apply Decision Analysis to solve them on the basis of maximization of eNPV.
- San Francisco, USA
- November 14-15 | 2023
- 8:00 - 17:00 Local Time
-
Course Leader: Dr. Richard Bayney,
President & Founder of Project & Portfolio Value Creation.
REGISTRATION
Conference
Ticket | November 16-17-
Access to All Conference Sessions of the 20th American Pharma and Biotech Project, Program and Portfolio Management Conference
-
Access to Post Conferences Networking
-
Conference Materials
-
Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch
Masterclass
Ticket | November 14-15-
Access to Project, Program, and Portfolio Risk Analysis Masterclass with Industry Veteran Dr. Richard Bayney.
-
One-on-one coaching
-
Copy of 2022's “The State of Portfolio Management” Benchmark Report
-
Design sessions for direct application
-
Benchmarks to identify your organization's performance gaps
Masterclass + Conference
Ticket | November 14-17-
Grants all Masterclass and Conference Ticket Benefits including access to the Project, Program, and Portfolio Risk Analysis Masterclass + 20th American Pharma and Biotech Project, Program and Portfolio Management Conference at a special rate.
BECOME A PARTNER
OF THIS EVENT-
Present on the Main Stage
-
Hold an exhibit at this event
-
Showcase your Brand in Marketing Material
-
Gain exposure through alternative partnership benefits
event partners
GOLD SPONSOR
Founded in 2017, Intelligencia AI™ is at the forefront of applying artificial intelligence (AI) and expertly curated scientific data to the drug development process to reduce risk and increase the probability of success. The SaaS-based platform, Portfolio Optimizer™, provides data and actionable insights for the pharmaceutical industry to reduce bias when evaluating the probability of technical and regulatory success (PTRS) and phase transitions for programs in clinical development at critical points in the drug development process.
STRATEGIC SPONSOR
Planview has one mission: to build the future of connected work, from ideas to impact. Planview helps organizations accelerate the achievement of what matters most, supporting our customers from need to speed, from passion to progress, and from overhead to optimization. Our connected platform of solutions underpins the business and digital transformations of more than 4,500 customers globally, including 59 of the Fortune 100. Planview empowers enterprises to improve time-to-market and predictability, increase efficiency to unlock capacity, and ensure their most strategic initiatives deliver the desired business outcomes.
GOLD SPONSOR
Planisware is a global provider of software solutions for project portfolio management. Planisware solutions are specifically designed to support product development, engineering and IT business processes. For more than 20 years, Planisware has been helping its customers to achieve strategic and innovative excellence, make valid business decisions and increase portfolio value. Today, over 500 companies worldwide rely on Planisware products to manage their projects, resources and portfolios.